Compounds > 4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl
Page last updated: 2024-11-07
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl
Description
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl: metabolite of polychlorinated biphenyl cpds [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)biphenyl : An member of the class of biphenyls that is 2,2',5,5'-tetrachlorobiphenyl in which the 4 and 4' positions are substituted by methylsulfonyl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 115069 |
CHEBI ID | 49809 |
MeSH ID | M0129971 |
Synonyms (17)
Synonym |
bmstbp |
4,4'-bis([h]methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl |
1UTR |
CHEBI:49809 |
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl |
66640-68-4 |
2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)-1,1'-biphenyl |
2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)biphenyl |
DB08373 |
1,1'-biphenyl, 2,2',5,5'-tetrachloro-4,4'-bis(methylsulfonyl)- |
rx2c8qlh24 , |
unii-rx2c8qlh24 |
DTXSID60216807 |
4,4'-bis(methylsulfonyl)-2,2',5,5'-tetrachloro-biphenyl |
4,4'-bis((h)methylsulfonyl)-2,2',5,5'-tetrachlorobiphenyl |
Q27097588 |
PD004458 |
Drug Classes (3)
Class | Description |
sulfone | An organosulfur compound having the structure RS(=O)2R (R =/= H). |
biphenyls | Benzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond. |
dichlorobenzene | Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (2)
Activation Measurements
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.17
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.17 (24.57) | Research Supply Index | 2.40 (2.92) | Research Growth Index | 4.56 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |